RxDoctor Payments Data

Michel Lacroix, MD

Neurological Surgery · Wilkes Barre, PANPI 1316190168

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Novocure Inc. at 34.0% of the total. Reporting peaked in 2019 at $11,264 and has fallen 99.7% since, to $39 in 2023.

$14,842in general payments, 2019–2025

Across 64 payments — averaging $231.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$5K
  • Medtronic$5K
  • Monteris Medical Corporation$2K
  • Brainlab, Inc.$2K
  • Insightec,inc$162
  • Zap Surgical Systems, Inc.$118
  • plus $72 from 1 others
$62,013in research payments, 2019–2025

Across 19 payments — averaging $3263.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$54K
  • Novocure Inc.$8K

What the payments were for

  • Speaking & faculty fees$5,50037%
  • Travel & lodging$6,79746%
  • Food & beverage$2,54517%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novocure Inc.12$5,049
Medtronic(2 entities)35$4,636
Monteris Medical Corporation7$2,403
Brainlab, Inc.6$2,402
Insightec,inc1$162
Zap Surgical Systems, Inc.1$118
Johnson & Johnson2$72

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,842 in reported general payments places this provider in the 75th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$43,458
Medicare patients
66
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Wilkes Barre

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →